{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:13:04Z","timestamp":1789776784619,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["212252\/Z\/18\/Z"],"award-info":[{"award-number":["212252\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clim.2023.109761","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T08:48:05Z","timestamp":1694162885000},"page":"109761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["A novel mutation in EROS (CYBC1) causes chronic granulomatous disease"],"prefix":"10.1016","volume":"255","author":[{"given":"Paige M.","family":"Mortimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esme","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Shanbhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve L.","family":"Coomber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talat H.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyra","family":"Randzavola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Bhattad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2023.109761_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733918","article-title":"Beyond the extra respiration of phagocytosis: NADPH oxidase 2 in adaptive immunity and inflammation","volume":"12","author":"Mortimer","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109761_bb0010","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.20161382","article-title":"Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity","volume":"214","author":"Thomas","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2023.109761_bb0015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jaci.2018.09.019","article-title":"EROS\/CYBC1 mutations: decreased NADPH oxidase function and chronic granulomatous disease","volume":"143","author":"Thomas","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109761_bb0020","series-title":"Title EROS-mediated control of NOX2 and P2X7 biosynthesis","author":"Randzavola","year":"2021"},{"key":"10.1016\/j.clim.2023.109761_bb0025","first-page":"9","article-title":"A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease","author":"Arnadottir","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2023.109761_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109316","article-title":"Characterization of AR-CGD female patient with a novel homozygous deletion in CYBC1 gene presenting with unusual clinical phenotype","volume":"251","author":"Chiriaco","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109761_bb0035","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.clim.2023.109761_bb0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4049\/jimmunol.1900448","article-title":"Functional expression of the P2X7 ATP receptor requires eros","volume":"204","author":"Ryoden","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2023.109761_bb0045","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.2020005590","article-title":"Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults","volume":"136","author":"Chiesa","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clim.2023.109761_bb0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood.2020007891","article-title":"HCT for CGD? Yes, and the sooner the better","volume":"136","author":"Morris","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clim.2023.109761_bb0055","author":"Leiding"},{"key":"10.1016\/j.clim.2023.109761_bb0060","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1371\/journal.pone.0005234","article-title":"Chronic granulomatous disease: the European experience","volume":"4","author":"van den Berg","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109761_bb0065","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3389\/fimmu.2020.01617","article-title":"Hematopoietic cell transplantation for chronic granulomatous disease in Japan","volume":"11","author":"Yanagimachi","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.clim.2023.109761_bb0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000496181","article-title":"Common infections and target organs associated with chronic granulomatous disease in Iran","volume":"179","author":"Mortaz","year":"2019","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.clim.2023.109761_bb0075","doi-asserted-by":"crossref","first-page":"639226","DOI":"10.3389\/fimmu.2021.639226","article-title":"Second report of chronic granulomatous disease in Jordan: clinical and genetic description of 31 patients from 21 different families, including families from Lybia and Iraq","volume":"12","author":"Bakri","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109761_bb0080","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1182\/blood-2009-07-231498","article-title":"A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40phox and selective defects in neutrophil NADPH oxidase activity","volume":"114","author":"Matute","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clim.2023.109761_bb0085","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1172\/JCI97116","article-title":"Inherited p40phox deficiency differs from classic chronic granulomatous disease","volume":"128","author":"van de Geer","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2023.109761_bb0090","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jmii.2022.06.005","article-title":"Clinical features and outcomes of patients with chronic granulomatous disease in Taiwan","volume":"56","author":"Lin","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.clim.2023.109761_bb0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cei.12202","article-title":"Molecular diagnosis of chronic granulomatous disease","volume":"175","author":"Roos","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2023.109761_bb0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s15010-009-8238-9","article-title":"Femoral osteomyelitis due to Cladophialophora arxii in a patient with chronic granulomatous disease","volume":"37","author":"Shigemura","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.clim.2023.109761_bb0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaci.2015.11.041","article-title":"Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases","volume":"138","author":"Conti","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109761_bb0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10875-017-0382-x","article-title":"Infection profile in chronic granulomatous disease: a 23-year experience from a tertiary care center in North India","volume":"37","author":"Rawat","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109761_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.625320","article-title":"Clinical, immunological, and molecular profile of chronic granulomatous disease: a multi-centric study of 236 patients from India","volume":"12","author":"Rawat","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623005247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623005247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:10:24Z","timestamp":1761495024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623005247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":23,"alternative-id":["S1521661623005247"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109761","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.21.23286144","asserted-by":"object"}]},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel mutation in EROS (CYBC1) causes chronic granulomatous disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109761"}}